Long-term prognosis of steroid-dependent sensorineural hearing loss

Audiology and Neurotology

Volumn 14, Issue 1, 2008, Pages 26-34

  Kanzaki, Jin ^a,b,c   Kanzaki, Sho ^a   Ogawa, Kaoru ^a  

^a KEIO UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c NONE   (Japan)

Author keywords

Long term prognosis; Steroid dependent sensorineural hearing loss; Takayasu's arteritis

Indexed keywords

CYTOKINE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INNER EAR; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CODING; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AUDIOMETRY, PURE-TONE; CHILD; DISEASE PROGRESSION; EAR, INNER; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; MIDDLE AGED; PROGNOSIS; SPEECH DISCRIMINATION TESTS; STEROIDS; TAKAYASU ARTERITIS;

EID: 49949102393     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000151587     Document Type: Article

References (30)

1. Adams JC: Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 2002;23:316-322.
2. Fujioka M, Kanzaki S, Okano HJ, Masuda M, Ogawa K, Okano H: Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res 2006;83:575-583.
3. Gloddek B, Lamm K, Arnold W: Pharmacological influence on inner ear endothelial cells in relation to the pathogenesis of sensorineural hearing loss. Adv Otorhinolaryngol 2002;59:75-83.
4. Harris JP, Sharp PA: Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990;100:516-524.
5. Hirose K, Westrum LE, Stone JS, Zirpel L, Rubel EW: Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann NY Acad Sci 1999;884:389-409.
6. Hughes GB, Moscicki R, Barna BP, San Martin JE: Laboratory diagnosis of immune inner ear disease. Am J Otol 1994;15:198-202.
7. Ito T, Watanabe T, Aoyagi M: Atypical Cogan's syndrome with steroid responsive sensorineural hearing loss. Audiol Jpn 2004;47:175-180.
8. Jeong HJ, Hong SH, Park RK, Shin T, An NH, Kim HM: Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-κB on HEI-OC1 cells. Hear Res 2005;207:59-67.
9. Kanzaki J, Ino T, Takahashi M: Clinical investigations on fluctuating hearing loss without vertigo. Audiol Jpn 1975;18:88-98.
10. Kanzaki J, O-Uchi T: Steroid-responsive bilateral sensorineural hearing loss and immune complexes. Arch Otorhinolaryngol 1981;230:5-9.
11. Kanzaki J, O-Uchi IT: Circulating immune complexes in steroid-responsive sensorineural hearing loss and the long-term observation. Acta Otolaryngol 1983;393(suppl):77-84.
12. Kanzaki J, O-Uchi T, Tsuchihashi N: Steroid-responsive sensorineural hearing loss: combination therapy with prednisolone and Saireito. ORL J Otorhinolaryngol Relat Spec 1993;55:24-29.
13. Kanzaki J: Steroid responsive sensorineural hearing loss (in Japanese). Otol Jpn 1994a;4:146-153.
14. Kanzaki J, Inoue Y, O-Uchi T: Immunological findings of serological tests in steroid-responsive sensorineural hearing loss. Acta Otolaryngol Suppl 1994b;514:66-69.
15. Kanzaki J: Immune-mediated sensorineural hearing loss. Acta Otolaryngol Suppl 1994c;514:70-72.
16. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS: Takayasu arteritis. Ann Intern Med 1994;120:919-929.
17. Kunihiro T, Kanzaki J, O-Uchi T, Yoshida A: Steroid-responsive sensorineural hearing loss associated with aortitis syndrome. ORL J Otorhinolaryngol Relat Spec 1990;52:86-95.
18. Kusakari C, Hozawa K, Koike S, Kyogoku M, Takasaka T: MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 1992;157:82-86.
19. Loveman DM, de Comarmond C, Cepero R, Baldwin DM: Autoimmune sensorineural hearing loss: clinical course and treatment outcome. Semin Arthritis Rheum 2004;34:538-543.
20. Masuda M, Nagashima R, Kanzaki S, Fujioka M, Ogita K, Ogawa K: Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res 2006;1068:237-247.
21. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-589.
22. Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB Jr, Bloch KJ: Serum antibody to inner ear proteins in patients with progressive hearing loss: correlation with disease activity and response to corticosteroid treatment. JAMA 1994;272:611-616.
23. Nomura Y, Kitamura K: Abrupt (sharp cut) type sensorineural hearing loss - a human temporal bone study. Auris Nasus Larynx 1979;6:13-21.
24. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G: Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999;100:55-60.
25. Rarey KE, Luttge WG: Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res 1989;41:217-221.
26. Raza K, Karokis D, Kitas GD: Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 1998;37:369-372.
27. Siglock TJ, Brookler KH: Sensorineural hearing loss associated with Takayasu's disease. Laryngoscope 1987;97:797-800.
28. Smith JC, Peck JE, Ray LI, Smith EC: Aortoarteritis and sensorineural hearing loss in an adolescent black male. Am J Otolaryngol 2004;25:370-376.
29. Sone M, Schachern PA, Paparella MM, Morizono N: Study of systemic lupus erythematosus in temporal bones. Ann Otol Rhinol Laryngol 1999;108:338-344.
30. ten Cate WJ, Zuo J, Lautermann J, Altenhoff P, Rarey KE: Development of 11 beta-hydroxysteroid dehydrogenase expression in the rat cochlea. Acta Otolaryngol 1997;117:841-844.